O'Brien Greene & Co’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.56M | Sell |
6,146
-150
| -2% | -$35K | 0.43% | 42 |
|
|
2026
Q1 | $1.54M | Hold |
6,296
| – | – | 0.44% | 41 |
|
|
2025
Q4 | $1.3M | Sell |
6,296
-50
| -0.8% | -$9.89K | 0.39% | 47 |
|
|
2025
Q3 | $1.18M | Sell |
6,346
-112
| -2% | -$19.2K | 0.36% | 48 |
|
|
2025
Q2 | $986K | Sell |
6,458
-400
| -6% | -$61.5K | 0.32% | 49 |
|
|
2025
Q1 | $1.14M | Sell |
6,858
-50
| -0.7% | -$7.82K | 0.38% | 49 |
|
|
2024
Q4 | $999K | Sell |
6,908
-88
| -1% | -$13.6K | 0.32% | 57 |
|
|
2024
Q3 | $1.13M | Sell |
6,996
-2,571
| -27% | -$410K | 0.35% | 52 |
|
|
2024
Q2 | $1.4M | Buy |
9,567
+797
| +9% | +$119K | 0.44% | 45 |
|
|
2024
Q1 | $1.39M | Hold |
8,770
| – | – | 0.46% | 45 |
|
|
2023
Q4 | $1.37M | Hold |
8,770
| – | – | 0.48% | 41 |
|
|
2023
Q3 | $1.37M | Hold |
8,770
| – | – | 0.5% | 42 |
|
|
2023
Q2 | $1.45M | Hold |
8,770
| – | – | 0.5% | 40 |
|
|
2023
Q1 | $1.36M | Hold |
8,770
| – | – | 0.51% | 41 |
|
|
2022
Q4 | $1.55M | Sell |
8,770
-18,236
| -68% | -$3.15M | 0.59% | 41 |
|
|
2022
Q3 | $4.41M | Buy |
27,006
+18,003
| +200% | +$3.05M | 0.58% | 41 |
|
|
2022
Q2 | $1.6M | Sell |
9,003
-258
| -3% | -$46K | 0.6% | 41 |
|
|
2022
Q1 | $1.64M | Sell |
9,261
-512
| -5% | -$87.1K | 0.54% | 41 |
|
|
2021
Q4 | $1.67M | Sell |
9,773
-377
| -4% | -$61.7K | 0.55% | 40 |
|
|
2021
Q3 | $1.64M | Sell |
10,150
-26,628
| -72% | -$4.54M | 0.6% | 39 |
|
|
2021
Q2 | $6.06M | Buy |
36,778
+1,570
| +4% | +$260K | 2.16% | 14 |
|
|
2021
Q1 | $5.79M | Buy |
35,208
+726
| +2% | +$117K | 2.29% | 16 |
|
|
2020
Q4 | $5.43M | Buy |
34,482
+2,695
| +8% | +$398K | 2.23% | 15 |
|
|
2020
Q3 | $4.73M | Sell |
31,787
-194
| -0.6% | -$28.7K | 2.25% | 16 |
|
|
2020
Q2 | $4.5M | Sell |
31,981
-238
| -0.7% | -$34.7K | 2.38% | 14 |
|
|
2020
Q1 | $4.22M | Sell |
32,219
-120
| -0.4% | -$17K | 2.81% | 11 |
|
|
2019
Q4 | $4.72M | Sell |
32,339
-1,830
| -5% | -$248K | 2.4% | 12 |
|
|
2019
Q3 | $4.42M | Sell |
34,169
-1,660
| -5% | -$219K | 2.37% | 12 |
|
|
2019
Q2 | $4.99M | Sell |
35,829
-287
| -0.8% | -$39.7K | 2.62% | 9 |
|
|
2019
Q1 | $5.05M | Sell |
36,116
-65
| -0.2% | -$8.71K | 2.55% | 9 |
|
|
2018
Q4 | $4.67M | Buy |
+36,181
| New | +$5.05M | 2.78% | 6 |
|
Other funds holding JNJ
O'Brien Greene & Co's JNJ Position: Q2 2026 in Review
O'Brien Greene & Co reduced its Johnson & Johnson (JNJ) stake by 2.4% in Q2 2026, selling an estimated $35K and leaving 6,146 shares worth $1.56M. The position accounts for 0.43% of the portfolio, ranked #42.
O'Brien Greene & Co first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.06M in Q2 2021. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- O'Brien Greene & Co held 6,146 shares of Johnson & Johnson worth $1.56M as of Q2 2026.
- O'Brien Greene & Co sold 150 Johnson & Johnson shares in Q2 2026, an estimated $35K.
- Johnson & Johnson made up 0.43% of O'Brien Greene & Co's portfolio in Q2 2026, its #42 holding.
- O'Brien Greene & Co first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- O'Brien Greene & Co's Johnson & Johnson position peaked at $6.06M in Q2 2021.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on O'Brien Greene & Co's 13F filing for Q2 2026, filed 6 Aug 2026.